PRX-08066

· Epix Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRX-08066, covering 2008-05-29 to 2009-07-30. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing